General Information
Version
2.0
Revision date
2021-04-07
Product name
DOWTHERM A Heat Transfer Fluid
1.2.1 Relevant identified uses
Intended as a heat transfer fluid for closed-loop systems. For industrial use only We recommend that you use this product in a manner consistent with the listed use. If your intended use is not consistent with the stated use, please contact your sales or technical service representative
Emergency telephone
00 49 4146 91 2333, 0049 4141 3679
Icons in SDS
Company Information
company name
DOW DEUTSCHLAND ANLAGENGESELLSCHAFT MBH
e-mail address of the competent person responsible for the Safety Data Sheet
SDSQuestion@dow.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H335, H400, H410
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Hazard statements
H315 Causes skin irritation. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H410 Very toxic to aquatic life with long lasting effects.
Precautionary statements
P261 Avoid breathing dust, fume, gas, mist, vapours and/or spray. P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves/ eye protection/ face protection. P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a + P312 POISON CENTER/ doctor if you feel unwell. P391 Collect spillage.
Contains
Diphenyl
2.3 Other hazards
This product contains no substances assessed to be PBT or vPvB at levels of 0.1% or higher. Endocrine disrupting properties
Environmental hazards
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Human Health: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
